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The present study was undertaken to examine if microdoses of ultra-high diluted arsenic trioxide (a potentized homeopathic
remedy, Arsenicum Album 200C, diluted 10−400 times) have hepatoprotective potentials in mice subjected to repeated injections
of arsenic trioxide. Arsenic intoxicated mice were divided into: (i) those receiving Arsenicum Album-200C daily, (ii) those
receiving the same dose of diluted succussed alcohol (Alc 200C) and (iii) another group receiving neither drug nor succussed
alcohol. Two other control groups were also maintained: one fed normal diet only and the other receiving normal diet and Alc-
200C. Toxicity biomarkers like aspartate and alanine aminotransferases,glutathione reductase, catalase, succinate dehydrogenase,
superoxide dismutase and reduced glutathione contents were periodically assayed keeping the observer “blinded”. Additionally,
electron microscopic studies and gelatin zymography for matrix metalloproteinases of liver tissues were made at day 90 and 120.
Blood glucose, hemoglobin, estradiol and testosterone contents were also studied. Compared to controls, Arsenicum Album-
200C fed mice showed positive modulations of all parameters studied, thereby providing evidence of protective potentials of the
homeopathicdrug against chronic arsenic poisoning.
1.Introduction
Microdoses of highly diluted arsenic trioxide (As2O3 10−400)
was chosen to validate its ameliorative potential against
repeated arsenic intoxication employing acceptable toxicity
biomarkers including speciﬁc hepato-toxicity denoting pro-
tocols. Some of these biomarkers were chosen because they
reﬂected degree ofhepatotoxicity, directly or indirectly being
inﬂuenced by the extent of toxicity caused by arsenic poison-
ing. Further, tissue damage and necrosis, often inﬂicted as
a result of arsenic poisoning, largely contribute to improper
liver function, that in turn, may cause hepatotoxicity. In
view of this, liver function tests, which include the assay
of enzymes like AST and ALT, were performed. These
tests can throw light on the extent of liver malfunctioning
and tissue damage in arsenic intoxicated mice. Therefore,
positive modulation of these parameters, if any, achieved
by the administration of the remedy, can be signiﬁcant and
supportive of its hepato-protective potential.
Inorganic arsenic (iAs) acts as a tumor-promoting agent
by inducing a rapid burst of reactive oxygen species (ROS)
in mammalian cells, resulting in oxidative stress [1, 2]a n d
carcinogenesis in man [3]. Cooperative defense systems
that protect the body from free radical damage include
the anti-oxidant enzymes [(superoxide dismutase (SOD),
catalase (CAT) and indirectly glutathione reductase (GRD)
and also GSH)] and nutrients. The study of these anti-
oxidant enzymes was therefore considered very pertinent.
Succinate dehydrogenase, an enzyme of the inner mitochon-
drial membrane is concerned with energy generation and
respiration;henceisessentialforcellsurvival.Thisparameter
was therefore also included in this study. The hematological
parameters like blood glucose, hemoglobin and hormonal
studies were performed since they depict the physiological
status of the body. Additionally, scanning and transmission
electron microscopic analyses and gelatin zymography for
analyzing expression pattern of matrix metalloproteinases
(MMPs) were performed at day 90 and 120.2 Evidence-Based Complementary and Alternative Medicine
2.Materials
2.1. Animals. Thirty-six healthy adult Swiss albino mice
(Mus musculus) of both sexes (30–40g) served as materials
for each series, six sacriﬁced at each ﬁxation interval.
All animal experiments were performed based on animal
ethics guidelines of Institutional Animal Ethics Committee,
University of Kalyani, under the supervision of Animal
Welfare Committee.
2.2. Experimental Design. Mice were randomized and sub-
divided into the following sub-sets.
2.3. Arsenic Intoxicated and Drug Fed Series. In all groups,
injection (intraperitoneal) with 0.016% As2O3 solution
(aqueous) at the rate of 1mL/100g body weight was
performed at an interval of 7 days (Gr-1) and sacriﬁced at
7, 15, 30, 60, 90 and 120 days, respectively, for all groups.
A sub-group was fed Ars Alb-200C (Gr-2) once daily till
sacriﬁced, which comprised the intoxicated drug fed series.
Another sub-group (Gr-3) was fed Alc 200C. Potentized
Ars Alb-200C was procured from Boiron Laboratory, Lyon,
France, as also the placebo (Alc-200 C), prepared with 70%
ethanol.
2.4. Control Series. A group of healthy mice was main-
tained on normal low protein diet (normal control—Gr-4).
Another group of healthy mice were fed diluted succussed
alcohol (Alc-200C) at the same rate as that of As203,b e c a u s e
the “vehicle” of the homeopathic remedy was ethyl alcohol
(alcohol control Gr-5).
Another group of mice was injected 0.016% As203 every
7th day and fed Alc-200C (intoxicated control) till they were
sacriﬁced, to learn about modulated eﬀect, if any, inducedby
ethyl alcohol on arsenic intoxicated mice.
3.Methods
3.1. Preparation of Tissue Homogenates. Liver and spleen
tissues were homogenized in phosphate buﬀer saline (pH
7.4) and centrifuged at 5000g for 60min. The supernatant
was used for assay of the marker enzymes (glutathione
reductase, superoxide dismutase, catalase and succinate
dehydrogenase), reduced glutathione, aspartate aminotrans-
ferase, alanine aminotransferase and protein estimation.
3.2. Biochemical Analysis. T h et i s s u eh o m o g e n a t ew a su s e d
for the assessment of AST and ALT [4], reduced glutathione
content [5], catalase [6], SOD[7], SDH[8],GRD [9, 10]a n d
protein [11].
3.3. Pathological Parameters. Blood glucose content was
assayed by the GOD-POD End point Colorimetric assay
kit supplied by Span Diagnostics Limited, Baroda (Code-
B0112), India.
Hemoglobin content was determined by Sahli’s method
with the help of a hemometer (Marienﬁeld, Germany).
Serum estradiol and testosterone content was assayed by
using the appropriate diagnostic kit (EQUPAR srl, Saronno,
Italy) with the aid of an ELISA Reader (ELDEX 3.8, USA) at
450nm.
3.4. Electron Microscopic Studies. T h ed e t a i l e dp r o c e d u r eo f
ﬁxation and section cutting for scanning and transmission
electron microscopy (SEMand TEM, respectively) have been
described elsewhere [12].
3.5.Level ofMMPExpression. Forthestudy ofMMP activity,
hepatic tissue was homogenized with phosphate buﬀersaline
(pH 7.4), followed by centrifugation in a cooling centrifuge
(REMI, C 24, India). The supernatant was collected and
subjected to gelatin zymography [12, 13].
3.6. Statistical Analysis and Scoring of Data. Statistical sig-
niﬁcance of the diﬀerence between experimental groups was
calculatedusing Student’spaired t-test [14]f ortw om ean s .A
P < .05was considered signiﬁcant. Oneway ANOVAhas also
been performed. The observers were “blinded” if the sample
belonged to “experimental” or “control” group at the time of
scoring the data.
4.Results
4.1. Biochemical Parameters. Arsenic intoxication caused a
signiﬁcant rise in AST (P < .05) (Table 1), ALT (P < .05)
(Table 2), AcP (Table 3)a n dA l k P( Table 4)a c t i v i t yl e v e l si n
liver and spleen tissues when compared to the control group.
ThesamewastrueforLPOactivity(Table 5).Administration
of Ars Alb-200C brought about considerable recuperation in
the activities of AST (.05 < P < .001), AcP, AlkP and ALT
(.01 < P < .001) and also of LPO. There was a palpable
reduction in GSH contents of both the tissues in arsenic
intoxicated mice (Table 6). These values were signiﬁcantly
increased (.05 < P < .001) in drug fed mice. Catalase activity
(Table 7) signiﬁcantly declined (.05 < P < .001) after arsenic
trioxide treatment in both the liver and spleen tissues.
However, there was a considerable increase of values in the
drug fed mice (P < .001) as compared to that of control.
Similarly, both the tissues revealed a substantial depletion
(.01 < P < .001) in the activities of SDH enzyme (Table 7)
afterrepeatedarsenictrioxideintoxication.ButArsAlb-200C
supplementation produced considerable repletion and the
values were comparable to that of controls (both Gr-1 and
Gr-3; P < .001).
The SOD levels (Table 8) showed a signiﬁcant decline
in its activity in both liver and spleen tissues after arsenic
trioxide treatment. In Ars Alb-200C fed mice, there was
considerable revival (P < .05) and the values were com-
parable to that of controls. Arsenic intoxication resulted
in signiﬁcant decrease (.05 < P < .001) of total GRD
content in both liver and spleen tissues when compared with
normal group. Administration of Ars Alb-200C resulted in
signiﬁcant increase (.05 < P < .001) in total GRD content
(Table 8) in both liver and spleen tissues as compared to
arsenic intoxicated group.Evidence-Based Complementary and Alternative Medicine 3
Table 1:Meanactivities ofAspartateaminotransferase(AST)(nM/mgprotein/min)inliverandspleenofdiﬀerent seriesofmiceatdiﬀerent
ﬁxation intervals.
Fixation intervals in days 30 Days 60 Days 90 Days 120 Days
Series Activity ± SE Activity ± SE Activity ± SE Activity ± SE
Liver
Negative control 0.014 ± 0.001 0.020 ± 0.000 0.011 ± 0.001 0.012 ± 0.001
Alcohol control 0.015 ± 0.002 0.022 ± 0.004 0.013 ± 0.000 0.013 ± 0.002
As2O3 0.03 ± 0.001 0.027 ± 0.001 0.035 ± 0.001 0.038 ± 0.002
As2O3 + Alcohol 0.033 ± 0.001 0.031 ± 0.003 0.040 ± 0.003 0.041 ± 0.000
As2O3 + Ars Alb-200C 0.026 ± 0.001∗∗ 0.032 ± 0.002 0.024 ± 0.003∗∗ 0.016 ± 0.004∗∗∗
Spleen
Negative control 0.011 ± 0.000 0.008 ± 0.001 0.016 ± 0.003 0.011 ± 0.000
Alcohol control 0.012 ± 0.001 0.005 ± 0.002 0.026 ± 0.001 0.012 ± 0.002
As2O3 0.025 ± 0.000 0.022 ± 0.001 0.031 ± 0.001 0.043 ± 0.000
As2O3 + Alcohol 0.027 ± 0.001 0.026 ± 0.001 0.033 ± 0.001 0.045 ± 0.001
As2O3 + Ars Alb-200C 0.02 ± 0.000∗∗∗ 0.012 ± 0.000∗∗∗ 0.022 ± 0.001∗∗∗ 0.018 ± 0.000∗∗∗
SE, Standard error; ∗∗P<. 01, ∗∗∗P<. 001, determined versus arsenic intoxicated Alcohol control.
Table 2: Mean activities of Alanine amino transferase (ALT) (nM/mg protein/min) in liver and spleen of diﬀerent series of mice at diﬀerent
ﬁxation intervals.
Fixation intervals in days 30 Days 60 Days 90 Days 120 Days
Series Activity ± SE Activity ± SE Activity ± SE Activity ± SE
Liver
Negative control 0.006 ± 0.001 0.008 ± 0.000 0.005 ± 0.004 0.005 ± 0.002
Alcohol control 0.008 ± 0.002 0.005 ± 0.001 0.006 ± 0.001 0.006 ± 0.003
As2O3 0.012 ± 0.000 0.015 ± 0.000 0.019 ± 0.001 0.020 ± 0.000
As2O3 + Alcohol 0.016 ± 0.002 0.019 ± 0.001 0.021 ± 0.000 0.025 ± 0.005
As2O3 + Ars Alb-200C 0.014 ± 0.001 0.012 ± 0.000∗∗∗ 0.009 ± 0.001∗∗∗ 0.005 ± 0.000∗∗∗
Spleen
Negative control 0.003 ± 0.000 0.005 ± 0.001 0.002 ± 0.001 0.003 ± 0.000
Alcohol control 0.007 ± 0.001 0.005 ± 0.002 0.002 ± 0.000 0.006 ± 0.001
As2O3 0.011 ± 0.001 0.015 ± 0.001 0.020 ± 0.001 0.024 ± 0.000
As2O3 + Alcohol 0.020 ± 0.002 0.020 ± 0.000 0.021 ± 0.003 0.028 ± 0.001
As2O3 + Ars Alb-200C 0.012 ± 0.002∗ 0.007 ± 0.001∗∗∗ 0.005 ± 0.002∗∗ 0.004 ± 0.000∗∗∗
SE, Standard error; ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001, determined versus arsenic intoxicated Alcohol control.
Table 3: Mean activities of Acid phosphatase (AcP) (nM/mg protein/min) in liver and spleen of diﬀerent series of mice at diﬀerent ﬁxation
intervals.
Fixation intervals in days 30 Days 60 Days 90 Days 120 Days
Series Activity ± SE Activity ± SE Activity ± SE Activity ± SE
Liver
Negative control 0.041 ± 0.003 0.047 ± 0.001 0.010 ± 0.000 0.022 ± 0.011
Alcohol control 0.034 ± 0.005 0.046 ± 0.002 0.031 ± 0.003 0.035 ± 0.000
As2O3 0.076 ± 0.001 0086 ± 0.003 0.054 ± 0.003 0.066 ± 0.000
As2O3 + Alcohol 0.085 ± 0.001 0.090 ± 0.001 0.057 ± 0.003 0.079 ± 0.000
As2O3 + Ars Alb-200C 0.083 ± 0.002 0.069 ± 0.001∗∗∗ 0.046 ± 0.001∗∗ 0.044 ± 0.001∗∗∗
Spleen
Negative control 0.03 ± 0.001 0.021 ± 0.003 0.035 ± 0.000 0.03 ± 0.001
Alcohol control 0.036 ± 0.002 0.22 ± 0.005 0.031 ± 0.008 0.038 ± 0.002
As2O3 0.074 ± 0.001 0.077 ± 0.003 0.085 ± 0.001 0.092 ± 0.003
As2O3 + Alcohol 0.076 ± 0.002 0.086 ± 0.004 0.089 ± 0.005 0.098 ± 0.001
As2O3 + Ars Alb-200C 0.068 ± 0.001∗∗ 0.057 ± 0.002∗∗∗ 0.054 ± 0.005∗∗∗ 0.051 ± 0.003∗∗
SE, Standard error; ∗∗P<. 01, ∗∗∗P<. 001, determined versus intoxicated Alcohol control.4 Evidence-Based Complementary and Alternative Medicine
Table 4: Mean activities of Alkaline phosphatase (AlkP) (nM/100mg protein/min) in liver and spleen of diﬀerent series of mice at diﬀerent
ﬁxation intervals.
Fixation intervals in days 30 Days 60 Days 90 Days 120 Days
Series Activity ± SE Activity ± SE Activity ± SE Activity ± SE
Liver
Negative control 0.018 ± 0.001 0.012 ± 0.001 0.018 ± 0.001 0.018 ± 0.002
Alcohol control 0.037 ± 0.001 0.013 ± 0.002 0.024 ± 0.002 0.024 ± 0.003
As2O3 0.031 ± 0.002 0.035 ± 0.000 0.036 ± 0.002 0.042 ± 0.001
As2O3 + Alcohol 0.035 ± 0.003 0.039 ± 0.006 0.041 ± 0.001 0.046 ± 0.000
As2O3 + Ars Alb-200C 0.033 ± 0.001 0.025 ± 0.002 0.023 ± 0.000∗∗∗ 0.026 ± 0.001∗∗∗
Spleen
Negative control 0.025 ± 0.002 0.022 ± 0.003 0.012 ± 0.001 0.014 ± 0.001
Alcohol control 0.031 ± 0.001 0.026 ± 0.002 0.021 ± 0.001 0.021 ± 0.000
As2O3 0.030 ± 0.001 0.034 ± 0.004 0.043 ± 0.002 0.043 ± 0.002
As2O3 + Alcohol 0.037 ± 0.002 0.038 ± 0.002 0.045 ± 0.001 0.039 ± 0.003
As2O3 + Ars Alb-200C 0.034 ± 0.006 0.031 ± 0.002∗ 0.037 ± 0.001∗∗ 0.028 ± 0.001∗∗
SE, Standard error; ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001, determined versus intoxicated Alcohol control.
Table 5:Meanlipidperoxidation (LPO)(nm/MDA/mgwettissue)inliverandspleen ofdiﬀerent seriesofmice atdiﬀerent ﬁxationintervals.
Fixation intervals in days 30 Days 60 Days 90 Days 120 Days
Series Activity ± SE Activity ± SE Activity ± SE Activity ± SE
Liver
Negative control 0.089 ± 0.020 0.05 ± 0.002 0.04 ± 0.001 0.044 ± 0.000
Alcohol control 0.094 ± 0.003 0.056 ± 0.005 0.094 ± 0.002 0.080 ± 0.009
As2O3 0.262 ± 0.013 0.277 ± 0.031 0.292 ± 0.025 0.372 ± 0.012
As2O3 + Alcohol 0.281 ± 0.010 0.246 ± 0.028 0.298 ± 0.003 0.416 ± 0.009
As2O3 + Ars Alb-200C 0.229 ± 0.010∗ 0.235 ± 0.028 0.139 ± 0.002∗∗∗ 0.093 ± 0.005∗∗∗
Spleen
Negative control 0.17 ± 0.002 0.105 ± 0.02 0.105 ± 0.002 0.030 ± 0.011
Alcohol control 0.185 ± 0.003 0.087 ± 0.004 0.118 ± 0.003 0.022 ± 0.005
As2O3 0.242 ± 0.041 0.272 ± 0.028 0.282 ± 0.002 0.296 ± 0.015
As2O3 + Alcohol 0.262 ± 0.040 0.278 ± 0.006 0.296 ± 0.023 0.396 ± 0.010
As2O3 + Ars Alb-200C 0.232 ± 0.034 0.239 ± 0.014∗ 0.165 ± 0.004∗∗ 0.109 ± 0.006∗∗∗
SE, Standard error; ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001.
Table 6: Mean reduced glutathione (GSH) (nm/mgtissue) in liver and spleen of diﬀerent series of mice at diﬀerent ﬁxation intervals.
Fixation intervals in days 30 Days 60 Days 90 Days 120 Days
Series Activity ± SE Activity ± SE Activity ± SE Activity ± SE
Liver
Negative control 0.006 ± 0.001 0.006 ± 0.002 0.007 ± 0.001 0.009 ± 0.001
Alcohol control 0.003 ± 0.001 0.003 ± 0.001 0.007 ± 0.002 0.007 ± 0.001
As2O3 0.004 ± 0.000 0.002 ± 0.001 0.001 ± 0.000 0.001 ± 0.000
As2O3 + Alcohol 0.005 ± 0.000 0.003 ± 0.001 0.002 ± 0.000 0.001 ± 0.000
As2O3 + Ars Alb-200C 0.005 ± 0.001 0.006 ± 0.000∗ 0.006 ± 0.000∗∗ 0.008 ± 0.000∗∗∗
Spleen
Negative control 0.005 ± 0.001 0.007 ± 0.001 0.009 ± 0.001 0.009 ± 0.002
Alcohol control 0.006 ± 0.002 0.005 ± 0.001 0.008 ± 0.001 0.008 ± 0.000
As2O3 0.004 ± 0.000 0.003 ± 0.000 0.002 ± 0.001 0.001 ± 0.000
As2O3 + Alcohol 0.004 ± 0.000 0.004 ± 0.000 0.002 ± 0.000 0.002 ± 0.000
As2O3 + Ars Alb-200C 0.004 ± 0.000 0.006 ± 0.001 0.007 ± 0.001∗∗ 0.008 ± 0.001∗∗∗
SE, Standard error; ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001, determined versus intoxicated Alcohol control.Evidence-Based Complementary and Alternative Medicine 5
Table 7: Catalase and Succinate dehydrogenase activities in liver and spleen of diﬀerent series of mice at 90 and 120 days ﬁxation interval.
Table-1 Succinate dehydrogenase (μmol/mg protein) Catalase (unit enzyme/mg protein)
Series 90 days 120 days 90 days 120 days
Liver Spleen Liver Spleen Liver Spleen Liver Spleen
Negative control 530.00 ± 1.58 487.00 ± 0.32 550.00 ± 1.26 500.00 ± 0.63 8.80 ± 0.003 5.50 ± 0.00 8.70 ± .001 8.20 ± 0.002
Alcohol control 541.00 ± 1.26 488.00 ± 0.63 557.00 ± 0.63 498.00 ± 0.95 8.60 ± 0.001 5.30 ± 0.01 8.50 ± 0.001 8.40 ± 0.001
As2O3 283.00 ± 1.90 272.00 ± 1.59 262.00 ± 0.63 261.00 ± 1.26 4.36 ± 0.005 2.30 ± 0.02 2.95 ± 0.003 1.86 ± 0.002
As2O3 + Alcohol 270.00 ± 0.63 256.00 ± 0.95 268.00 ± 0.95 230.00 ± 1.30 3.11 ± 0.002 1.90 ± 0.01 2.50 ± 0.01 1.40 ± 0.001
As2O3 +A r s
Alb-200C
495.00 ±
0.013∗∗∗
428.00 ±
0.01∗∗∗
512.00 ±
0.33∗∗∗
453.00 ±
1.38∗∗∗
6.1 ±
0.001∗∗∗
5.29 ±
0.003∗∗∗
6.69 ±
0.002∗∗∗
6.21 ±
0.002∗∗∗
SE, Standard error; ∗∗∗P<. 001, determined versus intoxicated Alcohol control.
Table 8: Glutathionereductase (μmol/mgprotein/min) andSuperoxide dismutase(unitenzyme/mg protein) inliver and spleen ofdiﬀerent
series of mice at 90 and 120 days ﬁxation interval.
Table-1 Glutathione reductase (μmol/mg protein/min) Superoxide dismutase (unit enzyme/mg protein)
Series 90 days 120 days 90 days 120 days
Liver Spleen Liver Spleen Liver Spleen Liver Spleen
Control 24 ± 0.010 20 ± 0.201 23.63 ± 0.010 20.85 ± 0.010 0.052 ± 0.031 0.050 ± 0.010 0.049 ± 0.010 0.051 ± 0.007
Alcohol control 21 ± 0.020 22 ± 0.110 22 ± 0.010 22 ± 1.30 0.056 ± 0.011 0.051 ± 0.012 0.051 ± 0.007 0.048 ± 0.010
As2O3 9.2 ± 0.122 10 ± 0.211 8 ± 0.158 8.9 ± 0.066 0.011 ± 0.006 0.015 ± 0.002 0.010 ± 0.001 0.012 ± 0.131
As2O3 + Alcohol 10 ± 0.447 12 ± 0.103 9 ± 0.224 11 ± 1.33 0.014 ± 0.010 0.013 ± 0.007 0.009 ± 0.003 0.010 ± 0.004
As2O3 +A r s
Alb-200C
19 ± 0.316∗∗∗ 16 ± 0.010∗∗∗ 22 ± 0.158∗∗∗ 18.6 ± 1∗∗ 0.037 ± 0.012 0.031 ± 0.010 0.061 ± 0.008∗∗∗ 0.052 ± 0.007∗∗
SE, Standard error; ∗∗P<. 01, ∗∗∗P<. 001, determined versus intoxicated Alcohol control.
4.2. Pathological Changes
4.2.1. Blood Hemoglobin. The hemoglobin content was
reduced in As2O3 + Alc200 C fed mice as compared to that
of normal controls. In Ars Alb-200C fed mice (Table 9), an
increase in hemoglobin level was obtained and the values
were comparable to that of controls.
4.2.2. Blood Glucose Content. In As2O3 and As2O3 +A l c
200C fed mice, an increase in blood sugar content was
observed at successive ﬁxation intervals, the increase being
signiﬁcant (P < .001) at day 90 only. The increase in blood
sugar content (Table 9) was so high that it exceeded the
normal level. In Ars Alb-200C fed group, there was also an
increase (P < .001) in blood sugar content except at day 60,
where a slight decrease in the said level was observed. Here,
theincrease was within thepermissible limits and notas high
as that of As2O3 and As2O3 + alcohol fed group.
4.2.3. Serum Estradiol and Testosterone Concentration. Com-
pared to intoxicated controls (Gr-1), a decrease in serum
estradiol and testosterone levels (Table 10) was obtained in
As2O3 and As2O3 + Alc200 C fed mice at day 90 and 120.
Administration of Ars Alb-200C resulted in an increase in
serum estradiol and testosterone levels in comparison to
arsenic trioxide treated group.
4.3.Transmission ElectronMicroscopic Study. Contrary to the
intact nuclear membrane observed in liver cells of normal
(Figure 1(a)) mice and arsenic intoxicated (Figures 1(b)–
1(d)) mice administered Ars Alb-200C (Figures 1(e)-1(f)),
thenuclearmembraneinlivercellsofAs2O3 intoxicatedmice
seemed to be broken.Destructive changeswere prominentin
the cristae of arsenic intoxicatedmice. Furthermore, number
ofvacuoleswasnoticedinarsenicintoxicatedmice.Cisternae
of the Golgi bodies of arsenic intoxicated mice were absent.
In arsenic intoxicated mice fed Ars Alb-200C, these features
were less conspicuous.
4.4. Scanning Electron Microscopic Study. The hepatocytes in
normal controls are shown in Figures 2(a) and 2(b).D a m -
aged hepatocytic cells were found in the arsenic intoxicated
series (Figure 2(c)). Relatively little damaged hepatocytes
were found in the intoxicated group that was fed Ars Alb-
200C (Figure 2(d)).
4.5. Metalloproteinase Activity. At 90- and 120-day ﬁxation
intervals, in As2O3 and As2O3 + Alc 200C fed mice, only
one band was expressed near 77kDa (Figure 3)w h i c h
presumably belonged to MMP family. However, in some
mice, this band was near 97 kDa, presumably belonging to a
diﬀerentMMPmember.Inthedrugfedseries,theexpression
of the single band appeared to be somewhat less.
4.6. Statistical Analysis. Many of the diﬀerences in data
revealedby Student’st-test havebeenfound to bestatistically
signiﬁcant at diﬀerent levels, as shown in Tables 1–10.
Similarly,resultsofone-wayANOVAalsorevealedsigniﬁcant6 Evidence-Based Complementary and Alternative Medicine
Table 9: Mean hemoglobin and Mean Blood sugar (mg/dl) content in diﬀerent series of mice at diﬀerent ﬁxation intervals.
Fixation intervals in days 30 Days 60 Days 90 Days 120 Days
Series Activity ± SE Activity ± SE Activity ± SE Activity ± SE
Mean hemoglobin
Negative control 14.1 ± 0.006 13.8 ± 0.007 16.6 ± 0.410 17.1 ± 0.170
Alcohol control 14.0 ± 0.009 14.6 ± 0.019 15.9 ± 0.039 17.0 ± 0.190
As2O3 12.8 ± 0.008 11.9 ± 0.004 11.2 ± 0.710 10.17 ± 0.190
As2O3 + Alcohol 11.6 ± 0.012 11.1 ± 0.004 10.7 ± 0.470 10.14 ± 1.490
As2O3 + Ars Alb-200C 14.0 ± 0.007∗∗∗ 12.7 ± 0.014∗∗∗ 15.17 ± 0.750∗∗∗ 16 ± 0.710∗∗
Mean Blood sugar
Negative control 84.731 ± 0.082 82.156 ± 0.054 85.76 ± 0.970 82.240 ± 0.840
Alcohol control 86.426 ± 0.056 84.286 ± 0.076 90.84 ± 1.760 80.740 ± 1.460
As2O3 111.743 ± 0.121 109.410 ± 0.238 162.45 ± 2.470 175.080 ± 2.890
As2O3 + Alcohol 117.412 ± 0.185 121.146 ± 0.089 180.48 ± 1.850 182.790 ± 1.050
As2O3 + Ars Alb-200C 104.131 ± 0.120∗∗∗ 97.420 ± 0.423∗∗∗ 99.78 ± 0.240∗∗∗ 92.460 ± 1.080∗∗∗
SE, Standard error; ∗∗P<. 01, ∗∗∗P<. 001, determined versus intoxicated Alcohol control.
Table 10: Mean Serum testosterone (ng/mL) and Mean Serum
Estradiol (pg/ml) levels in diﬀerent series of mice at diﬀerent
ﬁxation intervals.
Fixation intervals in days 90 Days 120 Days
Series Activity ± SE Activity ± SE
Mean Serum testosterone
Negative control 5.10 ± 0.160 5.40 ± 0.030
Alcohol control 5.60 ± 0.130 5.50 ± 0.040
As2O3 0.98 ± 0.010 1.21 ± 0.020
As2O3 + Alcohol 2.54 ± 0.020 2.68 ± 0.010
As2O3 + Ars Alb-200C 1.87 ± 0.020∗∗∗ 1.43 ± 0.015∗∗∗
Mean Serum Estradiol
Negative control 42.00 ± 1.900 46.00 ± 1.260
Alcohol control 48.00 ± 0.840 51.00 ± 1.580
As2O3 33.00 ± 0.630 32.00 ± 0.710
As2O3 + Alcohol 31.00 ± 1.260 28.00 ± 1.210
As2O3 + Ars Alb-200C 39.00 ± 1.260∗∗ 48.0 ± 0.840∗∗∗
SE, Standard error; ∗∗P<. 01, ∗∗∗P<. 001, determined versus intoxicated
Alcohol control.
diﬀerences among the diﬀerent parameters studied (Tables
11–13).
5.Discussion
Arsenic compound is a protoplasmic poison that can bind
to human sulphydryl-containing proteins with high aﬃnity.
Arsenic trioxide (As2O3), extracted from arsenic compound,
is a powerful ancient medication for a variety of ailments
with the principle of “using a toxic against another toxic” in
traditional Chinese medicine. Strikingly, As2O3 treatment in
aregime of10mg/dayofintravenousinfusion for28–60days
is eﬀective in patients with acute promyelocytic leukemia
(APL) without viable toxicity in refractory to the all-trans
retinoic acid (ATRA) and the conventional chemotherapy by
inducing apoptosis of APL cells [15]. Notably, As2O3 exerts a
broader anti-inﬂammatory activity by inhibition of nuclear
factor, NF-κB activation through induction of inhibitor of
κ-B expression in the airways [16]. Low dosage of As2O3
may have apotential beneﬁt in treating patientswith asthma,
especially in those with steroid-dependent and resistant
asthma. Overall, existing data suggest a beneﬁcial eﬀect of
As2O3 for the treatment of cancer and even inﬂammatory
diseases. However, that even a non-material dose derived
from dilution and succussions of As2O3 could show some
beneﬁcial eﬀects in the present study is of considerable
signiﬁcance and of some practical application as well. To
ascertain the exact amount of arsenic pushed inside the body
and simulate a condition of chronic arsenic intoxication,
mice were subjected to repeated injections of arsenic trioxide
that inﬂicted hepatic damage and oxidative stress that was
observed from a substantial increase in the activities of
the hepatic enzymes, namely ALT and AST. An increase in
the activity of these marker enzymes portrays possibility of
tissue necrosis and loss of functional integrity of hepatocyte
membrane. Reduction in the levels of ALT and AST towards
the respective normal values by administration of Ars
Alb-200C is an indication of the protective ability of the
potentized homeopathic drug as well as its ability to repair
hepatic tissue damage inﬂicted by As2O3. During hepatic
injury, superoxide radicals are known to be generated at the
site of damage, which in turn modulate activities of SOD
and CAT, resulting in the loss ofactivity and accumulation of
superoxide radical, which are responsible for damage of liver
tissue. Decreased CAT activity is linked to the exhaustion of
t h ee n z y m ea sar e s u l to fo x i d a t i v es t r e s sc a u s e db yA s 2O3.
SOD and CAT activities were brought down to near normal
after treatment with Ars Alb-200C. This gives a positive
indication regarding the protective eﬃcacy of the potentized
homeopathic drug.
Reduced glutathione (GSH) constitutes the ﬁrst line of
defense against free radicals. It plays an important role
in the regulation of cell proliferation and cellular defense
[17]. Exposure of cells to arsenic trioxide leads to the
depletion of GSH, which may also signify damage toEvidence-Based Complementary and Alternative Medicine 7
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Figure 1: Representative photomicrographs under TEM of liver sections of normal (a), arsenic intoxicated (b–d) and arsenic intoxicated
drug fed mice (e–f). BD, black droplet; ER, endoplasmic reticulum; NM, nuclear membrane; NU, nucleus; WD, white droplet.
the hepatic cells. Positive alterations in endogenous GSH
have been encountered in the present investigation after
administration of the homeopathic remedy, which is in line
with the activities of other biomarkers. The availability of
suﬃcient amount of GSH increased the detoxiﬁcation of
active metabolites of As2O3. Succinate dehydrogenase is a
membrane-bound dehydrogenase linked to the respiratory
chain and is a member of the Krebs’ cycle [18]. Positive
modulations encountered in the activity of this enzyme
and those of SOD and CAT in the drug fed mice lends
support to the protective ability of the remedy in cellular
and sub-cellular environments. GSSG is reduced to GSH by
glutathione reductase, which is NADPH-dependent. It plays
a signiﬁcant role in maintaining adequate amounts of GSH.
Accordingly,thereductionofGRDresultsindecreasingGSH
[18]. In As2O3 treated mice, the activity of GRD is markedly
decreased.AnincreaseinGRDactivityhighlightsthehepato-
protective ability of the remedy.
Elevated blood glucose levels in As2O3 and As2O3 +
alcohol fed mice was also considerably reduced in the drug
fed series. The level of blood hemoglobin was markedly
decreased in arsenic intoxicated group, but in the drug fed
mice the level slightly increased. Similarly, serum estradiol
andtestosteronelevelsdecreasedmarkedlyinarsenictrioxide8 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Representative photomicrographs under scanning electron microscopy of liver sections of normal (a–b), arsenic intoxicated (c)
and arsenic intoxicated drug fed (d) mice. (Magni- 1KX); H, hepatocyte; MD, mechanical disorder.
Table 11: One way ANOVA for diﬀerent hepatic enzymes.
Source of AST ALT LPO GSH Catalase SDH SOD
variation df F Sig. df F Sig. df F Sig. df F Sig. df F Sig. df F Sig. df F Sig.
Between
groups
23 14.72 0.000∗ 23 35.93 0.000∗ 23 990.89 0.000∗ 23 2.51 0.001∗ 23 54.52 0.000∗ 23 172.80 0.000∗ 23 2.62 0.000∗
Within
groups
72 72 72 72 72 72 72
∗P<. 05.
injected mice. Testosterone, an anabolic steroid, is responsi-
ble for the development and maintenance of male secondary
sex characters aswell asgrowth promoting eﬀects.Decreased
testosterone levels in males may indicate hypothalamic or
pituitary disorders or damage to the testis. Alternatively,
decrease in the level of serum testosterone could also be
implicated to a direct relationship with the increase in
toxicity due to arsenic intoxication. A positive correlation
can be drawn between increased SHA and an increase in
testosterone level. Positive changes in the levels of these
hormones were encountered in the drug fed mice. Eagon
et al. [19] showed an increased level of estradiol in females
of a rat model of hyperplasia.
An increase in the number of mitochondria, distorted
nuclei and large black lipid droplets was observed in TEM
study of liver tissues of arsenic treated mice. Similarly, in
SEM study, damaged hepatocytes and hepatic chords were
observed in arsenic intoxicated group. In the drug fed series,
however, these features were less marked, which would also
support the positive eﬀects of the drug in ameliorating
arsenic induced eﬀect at the ultrastructural level. MMPs
hydrolyze components of the extracellular matrices; these
proteases play a central role in many biological processes.
MMPs facilitate invasion and metastization of carcinoma
cells [20]. MMPs are a family of Zn2+-a n dC a 2+-dependent
endopeptidases secreted by both normal and transformed
cells, and capable of degrading collagenous and non-
collagenous components of extracellular matrix [21, 22].
Resultsofthepresentstudyrevealedahighlevelofexpression
of metalloproteinases. This is in conformity with high levels
of expression of metalloproteinases reported in pathological
conditions such as wound healing, angiogenesis, tumor
invasion, metastasis [23–26], arthritis, emphysema and
apoptosis [27, 28]. In the drug fed mice, no overexpression
of metalloproteinases was noticed. Therefore, the expression
ofMMPsorratherthelackofexpression providessubstantial
evidencein favor of their anti-tumorigenic eﬀectsat the gene
expression level.
How the ultra low doses of the potentized remedy
could bring about multiple changes in both enzymatic and
pathological parameters as well as many biomarkers is rather
unclear at the present state of our knowledge. Incidentally,Evidence-Based Complementary and Alternative Medicine 9
Table 12: One way ANOVA of diﬀerent spleen enzymes.
Source of variation AST activity ALT activity GSH activity CAT activity SDH activity SOD activity
df F Sig. df F Sig. df F Sig. df F Sig. df F Sig. df F Sig.
Between groups 23 39.131 0.000∗ 23 30.120 0.000∗ 23 3.160 0.000∗ 23 100.361 0.000∗ 23 91.231 0.000∗ 23 3.002 0.000∗
Within groups 72 72 72 72 72 72
∗P<. 05.
Table 13: One way ANOVA of blood parameters.
Source of Variation Blood Hb Blood Sugar Serum Testosterone Serum Estadiol
df F Sig. df F Sig. df F Sig. df F Sig.
Between groups 23 63.268 0.000∗ 23 750.120 0.000∗ 23 28.160 0.000∗ 23 20.361 0.000∗
Within groups 72 72 72 72
∗P<. 05.
M 1 2 3 4
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Figure 3: Gelatin zymogram of liver samples showing the expres-
sion of MMP in experimental mice at 120 days l. Lane 1, normal;
lane 2, As2O3;l a n e3 :A s 2O3 + Alc-200; lane 4, As2O3 +A r sA l b -
200; M, molecular weight marker.
Khuda-Bukhsh [29–32] proposed a working hypothesis that
one mechanism through which the potentized homeopathic
drugs act could be through regulation of expression of
certain relevant genes. This explanation seems plausible
b e c a u s ea l lt h eb i o m a r k e r st e s t e da r er e g u l a t e db ys p e c i ﬁ c
genetic regulatory mechanisms, and without involvement of
these regulatory mechanisms, such positive results could not
have been achieved.
6.Conclusion
The results of the present study suggests that Arsenicum
Album 200C can be used as an interim relief measure,
especially in high-risk arsenic contaminated areas, at least till
arsenic-free drinkingwaterorbetterstrategiestomanagethis
dreadful problem are available. However, this would need
further clinical trial, preferably by others, to validate the
ameliorative potentials for its homeopathic use in large scale
in the arsenic contaminated areas.
Acknowledgments
Aresearch grant fromBoironLab, Lyon,Franceto Prof.A.R.
Khuda Bukhsh is gratefully acknowledged. The authors are
thankful to Dr T.C. Nag, AIIMS, New Delhi for providing
necessary infrastructural support and expertise for electron
microscopic studies.
References
[1] E. Garc´ ıa-Ch´ avez, A. Santamar´ ıa, F. D´ ıaz-Barriga, P. Man-
deville, B. I. Ju´ arez, and M. E. Jim´ enez-Capdeville, “Arsenite-
inducedformationofhydroxylradicalinthestriatumofawake
rats,” Brain Research, vol. 976, no. 1, pp. 82–89, 2003.
[2] J. Pi, H. Yamauchi, Y. Kumagai et al., “Evidence for induction
of oxidative stress caused by chronic exposure of Chinese res-
idents to arsenic contained in drinking water,” Environmental
Health Perspectives, vol. 110, no. 4, pp. 331–336, 2002.
[3] S. Ahmad, K. T. Kitchin, and W. R. Cullen, “Arsenic species
that cause release of iron from ferritin and generation of
activated oxygen,” Archives of Biochemistry and Biophysics,v o l .
382, no. 2, pp. 195–202, 2000.
[ 4 ] H .U .B e r g m e y e ra n dE .B r e n t ,“ A m i n o t r a n s f e r a s e s , ”i n
Methods of Enzymatic Analysis, H. U. Bergmeyer, Ed., pp. 735–
760,VerlagChemieWeinheim.AcademicPress,NewYork,NY,
USA, 1974.
[5] G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochem-
istry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959.
[6] B. Chance and A. C. Maehly, “Assay of catalase and peroxi-
dase,” Methods in Enzymol, vol. 2, pp. 764–775, 1955.
[7] P. Kakkar, B. Das, and P. N. Viswanathan, “A modiﬁed
spectrophotometric assay of superoxide dismutase,” Indian
Journal of Biochemistry and Biophysics, vol. 21, no. 2, pp. 130–
132, 1984.
[8] E. C. Slater and W. D. Bonner, “The eﬀect of ﬂuoride on
succinicoxidasesystem,”BiochemicalJournal, vol.52,pp.185–
196, 1952.
[9] I. Carlberg andB.Mannervik,“Glutathionereductase levelsin
rat brain,”The Journal of Biological Chemistry,vol.250,no.14,
pp. 5475–5480, 1975.
[ 1 0 ]J .M o h a n d a s ,J .J .M a r s h a l l ,G .G .D u g g i n ,J .S .H o r v a t h ,
and D. Tiller, “Diﬀerential distribution of glutathione and
glutathione related enzymes in rabbit kidney: possible inter-
actions in analgesic neuropathy,” Cancer Research,v o l .4 4 ,p p .
5086–5091, 1984.10 Evidence-Based Complementary and Alternative Medicine
[ 1 1 ]O .H .L o w r y ,N .J .R o s e b r o u g h ,A .L .F a r r ,a n dR .J .
Randall, “Protein measurement with Folin-Phenol reagent,”
The Journal of Biological Chemistry, vol. 193, pp. 265–275,
1951.
[12] S. Pathak and A. R. Khuda-Bukhsh, “Assessment of hepato-
cellular damage and hematological alterations in mice chron-
ically fed p-dimethylaminoazobenzene and phenobarbital,”
Experimental and Molecular Pathology, vol. 83, pp. 104–111,
2007.
[ 1 3 ]P .C .B i l l i n g s ,J .M .H a b r e s ,D .C .L i a o ,a n dS .W .T u t t l e ,
“Human ﬁbroblasts contain a proteolytic activity which is
inhibited by the Bowman-Birk protease inhibitor,” Cancer
Research, vol. 51, no. 20, pp. 5539–5543, 1991.
[14] R. A. Fisher and F. Yates, Statistical Tables for Biological, Agri-
cultural and Medical Research, Oliver and Boyd, Edinburgh,
UK, 6th edition, 1963.
[ 1 5 ]P . - Z .Z h e n g ,K . - K .W a n g ,Q . - Y .Z h a n ge ta l . ,“ S y s t e m sa n a l -
ysis of transcriptome and proteome in retinoic acid/arsenic
trioxide-induced cell diﬀerentiation apoptosis of promye-
locytic leukemia,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 102, no. 21, pp.
7653–7658, 2005.
[ 1 6 ]L .F .Z h o u ,Y .Z h u ,X .F .C u i ,W .P .X i e ,A .H .H u ,a n dK .
S. Yin, “Arsenic trioxide, a potent inhibitor of NF-kappaB,
abrogates allergen-induced airway hyperresponsiveness and
inﬂammation,”Respiratory Research, vol. 7, p. 146, 2006.
[17] S. Karasaki, “Cell proliferation and subcellular localization of
alkaline phosphatase activity in rat liver parenchyma during
azo dye induced carcinogenesis,” Cancer Research,v o l .3 5 ,p p .
482–491, 1975.
[18] R. O. Recknagel, E. A. Glende, and R. S. Britton, “Free radical
damage and lipid peroxidation,” in Hepatotoxicology,R .G .
Meeks, S. D. Harrison, and R. J. Bull, Eds., pp. 401–436, CRC
Press, Boca Raton, Fla, USA, 1991.
[19] P. K. Eagon, N. Chandar, M. J. Epley, M. S. Elm, E. P. Brady,
and K. N. Rao, “Di(2-ethylhexyl)phthalate-induced changes
in liver estrogen metabolism and hyperplasia,” International
Journal of Cancer, vol. 58, no. 5, pp. 736–743, 1994.
[ 2 0 ] M .J .H e s l i n ,J .Y a n ,M .R .J o h n s o n ,H .W e i s s ,R .B .D i a s i o ,a n d
M. M. Urist, “Role of matrix metalloproteinases in colorectal
carcinogenesis,”Annals ofSurgery,vol.233,no.6,pp.786–792,
2001.
[21] L. A. Liotta, P. S. Steeg, and W. G. Stetler-Stevenson, “Cancer
metastasis and angiogenesis: an imbalance of positive and
negative regulation,” Cell, vol. 64, no. 2, pp. 327–336, 1991.
[22] L. M. Matrisian, “Metalloproteinases and their inhibitors in
matrix remodeling (Review),” Trends in Genetics,v o l .6 ,p p .
121–125, 1990.
[23] J. F. Woessner Jr., “Matrix metalloproteinases and their
inhibitors in connective tissue remodeling,” The FASEB Jour-
nal, vol. 5, no. 8, pp. 2145–2154, 1991.
[24] A. Y. Lee, K. T. Akers, M. Collier, L. Li, A. Z. Eisen, and J.
L. Seltzer, “Intracellular activation of gelatinase A (72-kDa
type IV collagenase) by normal ﬁbroblasts,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 94, no. 9, pp. 4424–4429, 1997.
[25] J.L.Seltzer,A.Y.Lee, K.Y.Akers,andM.Collier,“Activationof
72- kDa type IV collagenase/gelatinase by normal ﬁbroblasts
in collagen lattices is mediated by integrin receptors but is not
related to lattice contraction,” Experimental Cell Research,v o l .
213, pp. 365–374, 1994.
[26] H. Birkedal-Hansen, “Proteolytic remodeling of extracellular
matrix,”Current Opinion in Cell Biology,vol.7, no.5,pp. 728–
735, 1995.
[27] J. M. Ray and W. G. Stetler-Stevenson, “The role of matrix
metalloproteasesandtheirinhibitorsintissueinvasion,metas-
tasis and angiogenesis,” The European Respiratory Journal,v o l .
7, pp. 2062–2072, 1994.
[ 2 8 ]Z .W a n g ,R .J u t t e r m a n n ,a n dP .D .S o l o w a y ,“ T I M P - 2i s
required for eﬃcient activation of proMMP-2 in vivo,” The
Journal of Biological Chemistry, vol. 275, no. 34, pp. 26411–
26415, 2000.
[29] A. R. Khuda-Bukhsh, “Potentized homeopathic drugs act
through regulation of gene expression: a hypothesis to explain
their mechanismandpathwaysofactioninvivo,”Complemen-
tary Therapies in Medicine, vol. 5, pp. 43–46, 1997.
[30] A. R. Khuda-Bukhsh, “Towards understanding molecular
mechanisms of action of homeopathic drugs: an overview,”
Molecularand Cellular Biochemistry,vol.253,no.1-2,pp.339–
345, 2003.
[ 3 1 ]A .R .K h u d a - B u k h s h ,J .R .M o ﬀett, P. Arun, and M. A.
A. Namboodiri, “Laboratory research in homeopathy: pro,”
Integrative Cancer Therapies, vol. 5, no. 4, pp. 320–342, 2006.
[32] A. R. Khuda-Bukhsh and S. Pathak, “Homeopathic drug
discovery: theory update and methodological aspect,” Expert
Opinion on Drug Discovery, vol. 3, no. 8, pp. 979–990, 2008.